CD45 / CD14 Antibody (FITC/PE)
338€ (20 tests)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
CD45 / CD14 Antibody (FITC/PE)
category
Primary Antibodies
provider
Abbexa
reference
abx159410
tested applications
ELISA, FCM
Description
CD45/CD14 Antibody (FITC/PE) is a Mouse Monoclonal against CD45/CD14.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | CD45/CD14 |
| Host | Mouse |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | FITC, PE |
| Isotype | IgG2a, IgG1 |
| Size 1 | 20 tests |
| Size 2 | 50 tests |
| Form | Liquid |
| Tested Applications | ELISA, FCM |
| Buffer | PBS, pH 7.4, containing 0.09% sodium azide and 0.2% (w/v) BSA. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P08575 |
| Alias | LCA,LY5,B220,CD45,L-CA,T200,CD45R,GP180,IMD105,CD45,Leukocyte common antigen,Receptor-type tyrosine-protein phosphatase C |
| Background | Antibody anti-PTPRC |
| Status | RUO |
Descripción
PTPRC, also known as CD45, is a receptor-type tyrosine phosphatase primarily expressed in hematopoietic cells. It regulates antigen receptor signaling in lymphocytes by dephosphorylating inhibitory residues on Src family kinases such as Lck and Fyn. Structurally, PTPRC has an extracellular domain, a single transmembrane region, and two cytoplasmic phosphatase domains, with the first being catalytically active. It is critical for T-cell and B-cell activation, development, and immune response regulation. Mutations in PTPRC are linked to severe immunodeficiency disorders, including SCID, and its overexpression is associated with autoimmune diseases and leukemia.
Related Products
APC Anti-Rat CD45 (OX-1)
Ver ProductoAPC Anti-Mouse CD45(30-F11)
Ver Producto